NO964180L - Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer - Google Patents

Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer

Info

Publication number
NO964180L
NO964180L NO964180A NO964180A NO964180L NO 964180 L NO964180 L NO 964180L NO 964180 A NO964180 A NO 964180A NO 964180 A NO964180 A NO 964180A NO 964180 L NO964180 L NO 964180L
Authority
NO
Norway
Prior art keywords
alkenyl
cycloalkyl
alkyl
alkynyl
substituted
Prior art date
Application number
NO964180A
Other languages
English (en)
Norwegian (no)
Other versions
NO964180D0 (no
Inventor
Peter Moldt
Frank Watjen
Jorgen Scheel-Krueger
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Publication of NO964180D0 publication Critical patent/NO964180D0/no
Publication of NO964180L publication Critical patent/NO964180L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Addiction (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO964180A 1994-04-19 1996-10-02 Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer NO964180L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK44794 1994-04-19
DK133894 1994-11-24
PCT/EP1995/001358 WO1995028401A1 (fr) 1994-04-19 1995-04-12 Derives de tropane-2-aldoxime en tant qu'inhibiteurs de recaptage des neurotransmetteurs

Publications (2)

Publication Number Publication Date
NO964180D0 NO964180D0 (no) 1996-10-02
NO964180L true NO964180L (no) 1996-12-16

Family

ID=26064021

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964180A NO964180L (no) 1994-04-19 1996-10-02 Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer

Country Status (25)

Country Link
US (1) US5736556A (fr)
EP (1) EP0756596B1 (fr)
JP (1) JP2899418B2 (fr)
KR (1) KR100210417B1 (fr)
CN (1) CN1043763C (fr)
AT (1) ATE222587T1 (fr)
AU (1) AU690257B2 (fr)
BG (1) BG63259B1 (fr)
BR (1) BR9507489A (fr)
CA (1) CA2187309C (fr)
CZ (1) CZ284379B6 (fr)
DE (1) DE69527839T2 (fr)
DK (1) DK0756596T3 (fr)
EE (1) EE03877B1 (fr)
FI (1) FI965074A0 (fr)
GE (1) GEP19991749B (fr)
HU (1) HU215830B (fr)
LV (1) LV11738B (fr)
NO (1) NO964180L (fr)
NZ (1) NZ284075A (fr)
PL (1) PL183025B1 (fr)
RU (1) RU2134264C1 (fr)
SK (1) SK280875B6 (fr)
UA (1) UA49801C2 (fr)
WO (1) WO1995028401A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3462505B2 (ja) * 1995-10-13 2003-11-05 ノイロサーチ アクティーゼルスカブ 8−アザビシクロ[3.2.1]オクト−2−エン誘導体、それらの製造及び使用
US6241963B1 (en) * 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
RU2162469C2 (ru) * 1995-11-02 2001-01-27 Ньюросерч А/С Конденсированные тропановые производные в качестве ингибиторов обратного захвата нейромедиаторов
US5948933A (en) * 1997-07-11 1999-09-07 Organix, Inc. Tropane analogs and methods for inhibition of monoamine transport
BR9707636A (pt) 1996-02-22 1999-07-27 Neurosearch As Composto composição farmacêutica uso de um composto e processos para preparar composto e para tratar um distúrbio ou doença de um organismo animal vivo
US6232326B1 (en) 1998-07-14 2001-05-15 Jodi A. Nelson Treatment for schizophrenia and other dopamine system dysfunctions
US20040229908A1 (en) * 1999-07-13 2004-11-18 Jodi Nelson Compositions and methods for the treatment of Parkinson's disease and tardive dyskinesias
AU779955B2 (en) 1999-07-13 2005-02-24 Alpha Research Group, Llc Compositions and methods for the treatment of Parkinson's disease
US6667314B2 (en) 2000-05-26 2003-12-23 Pfizer, Inc. Tropane derivatives useful in therapy
CZ299102B6 (cs) * 2000-05-26 2008-04-23 Pfizer Inc. Tropanový derivát, zpusoby a meziprodukty pro jeho výrobu, léciva a lécivové kombinace s jeho obsahem
US20040106643A1 (en) * 2001-05-23 2004-06-03 Gouliaev Alex Haarh Tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US6610849B2 (en) * 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
US7381733B2 (en) 2001-11-30 2008-06-03 Neurosearch A/S Tropane derivatives having dopamine reuptake inhibitor activity for the treatment of ischemic diseases
DE10200943A1 (de) * 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
WO2003099783A2 (fr) * 2002-03-28 2003-12-04 President And Fellows Of Harvard College Composes de tropane
HRP20080052T3 (hr) 2003-10-03 2008-02-29 Pfizer Inc. Derivati tropana supstituirani imidazopiridinom santagonističkim djelovanjem na ccr5 receptor za liječenje hiv-a i upala
DK1675591T3 (da) 2003-10-16 2011-11-14 Neurosearch As Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
AU2005205882A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
EP1727547A1 (fr) * 2004-01-22 2006-12-06 Neurosearch A/S Composes pour une reduction soutenue du poids corporel
WO2006075976A1 (fr) * 2005-01-14 2006-07-20 Private Enterprise 'slavyanskaya Klinika' Utilisation d'un anesthesique local pour corriger un comportement alimentaire humain, et procede d'utilisation associe
EP1779851A1 (fr) 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Traitement du diabète

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3813404A (en) * 1972-11-15 1974-05-28 Sterling Drug Inc Tropane-2-carboxylates and derivatives
SU941369A1 (ru) * 1978-12-29 1982-07-07 Научно-исследовательский институт фармакологии АМН СССР Хлоргидраты W-аминоацильных эфиров тропан-3-ола как стимул торы центральной нервной системы
AT397962B (de) * 1985-12-27 1994-08-25 Madaus & Co Dr Verfahren zur herstellung von azoniaspironortropanolestern
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds

Also Published As

Publication number Publication date
JP2899418B2 (ja) 1999-06-02
SK128896A3 (en) 1997-04-09
HU9602707D0 (en) 1996-11-28
AU2257595A (en) 1995-11-10
FI965074A7 (fi) 1996-12-17
RU2134264C1 (ru) 1999-08-10
AU690257B2 (en) 1998-04-23
HUT75865A (en) 1997-05-28
CA2187309A1 (fr) 1995-10-26
CN1148854A (zh) 1997-04-30
WO1995028401A1 (fr) 1995-10-26
BG100883A (en) 1998-03-31
HU215830B (hu) 2001-05-28
EE03877B1 (et) 2002-10-15
FI965074A0 (fi) 1996-12-17
BR9507489A (pt) 1997-08-12
DE69527839D1 (en) 2002-09-26
CA2187309C (fr) 2000-11-21
SK280875B6 (sk) 2000-08-14
BG63259B1 (bg) 2001-07-31
EP0756596B1 (fr) 2002-08-21
EP0756596A1 (fr) 1997-02-05
NZ284075A (en) 1998-01-26
PL316876A1 (en) 1997-02-17
NO964180D0 (no) 1996-10-02
UA49801C2 (uk) 2002-10-15
US5736556A (en) 1998-04-07
CN1043763C (zh) 1999-06-23
DK0756596T3 (da) 2002-12-23
DE69527839T2 (de) 2003-01-02
LV11738B (en) 1997-12-20
MX9604966A (es) 1998-05-31
GEP19991749B (en) 1999-09-10
CZ298296A3 (en) 1997-06-11
PL183025B1 (pl) 2002-05-31
EE9600132A (et) 1997-04-15
LV11738A (lv) 1997-04-20
JPH09505607A (ja) 1997-06-03
CZ284379B6 (cs) 1998-11-11
KR100210417B1 (ko) 1999-07-15
ATE222587T1 (de) 2002-09-15

Similar Documents

Publication Publication Date Title
NO964180L (no) Tropan-2-aldoksimderivater som neurotransmitter-gjenopptaksinhibitorer
NO980919D0 (no) 8-azabicyklo(3.2.1)okt-2-ene derivater, deres fremstilling og anvendelse
UA49872C2 (uk) Похідні тропану, спосіб їх одержання, фармацевтична композиція та спосіб лікування
CA2160444A1 (fr) Derives de l&#39;aroylpiperidine
DK0858461T3 (da) Kondenserede tropanderivater som neurotransmittergenoptagelsesinhibitorer
YU40998A (sh) Derivati supstituisanog 1,2,3,4-tetrahidronaftalina
PL247096A1 (en) Agent for fighting against and/or preventing paralyzing effects of microorganisms and method of obtaining new derivatives of n-/2-nitrophenylo/-4-aminopyrimidines
AU7206398A (en) Piperidine derivatives as neurotransmitter re-uptake inhibitors
GB9825554D0 (en) Novel Compounds
JO2235B1 (en) Derivatives of phenyl
US4840967A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
TH10189A (th) อนุพันธ์ของกรด (สูตรเคมี) ที่มีหมู่แทนที่ฟลูออรีน
HUP0303691A2 (hu) Uretánszármazékok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application